Past Webinars Replays

Watch FREE trailers and find full video links to the past webinars in the series: Antibody Therapeutcis: Bench to Market

Image

Past Webinars

往期回放

Sort, filter, and search the past webinars. Play trailer for FREE or register to view full recordings of 30+ webinars
搜索,筛选,并 免费预览 往期webinar。注册成会员即可观看30+个webinar的完整录像

Filter by Category

Filter by Free / Member-Only

Sorting


discovery

Fundamentals of therapeutic antibody discovery

2017-06-24

Zhijian Lu

Biologics Discovery Lead, Novartis


upstream

Cell Line and Upstream Process Development for the Manufacture of Monoclonal Antibodies

2017-07-15

Zhong Liu

Upstream PD Lead, Adello Biologics


regulatory

Regulatory and Quality Considerations for the US filing of Monoclonal Antibody and Related Products

2017-08-05

Audrey Jia

COO, Data Revive


patent

Patenting Therapeutic Antibodies: Basics and Beyond

2017-09-02

Lin Sun-Hoffman

Founding Partner, Liu, Chen & Hoffman


clinical trials

Design and conduct of clinical trials – a primer

2017-09-23

Yong-Jiang Hei

CMO, Ambrx


business

How to raise money from Venture Capitalists

2017-10-21

Jonathan Wang

Senior Managing Director, OrbiMed Asia


discovery

Optimization of Therapeutic Antibody Sequence – The Art of Balance

2017-11-18

Yue Liu

CEO, Ab Studio


discovery

The application of transgenics and single B cell cloning technologies for therapeutic antibody discovery

2018-01-27

Xinyan Zhao

VP, Simcere BioPharma


downstream

Downstream process development for manufacturing monoclonal antibodies

2018-02-24

Hong Li

Director, Merck Research Laboratory


clinical trials

Ten Commands of Phase 3 Trial for Innovative Medicine and Biosimilar

2018-03-31

Yonghong Zhu

Project Lead , Roche Shanghai


regulatory

Introduction to US Regulatory Requirements and Processes

2018-05-12

Dahua Pan

Associated Director, Sanofi Genzyme


patent

Strategic Concerns in Antibody Patenting

2018-06-16

Li Feng

Partner, Garrett & Dunner, LLP


target biology

IO combinations: promises and challenges

2018-07-21

Yong Ben

CMO, BioAtla


downstream

Considerations of Protein Solubility for High Concentration Formulation Development

2018-08-25

Jifeng Zhang

Senior Director, Sanofi


business

Healthcare Industry Investment in 2018 & Antibody Drug Investment Practice

2018-09-15

John Wang

Excutive Partner, GTJA Investment Group


analytical

Regulatory Requirements for mAb & ADC – Quality

2018-10-20

Shufang Niu

Management, Associated Director


discovery

Discovery and Development of Mab Therapeutics against GPCR Targets

2018-12-09

Shuqian Jing

CEO, Gmax Biopharm


analytical

Introduction to Quality Control in Biopharmaceutical Industry

2019-01-26

Roujian Zhang

Head of Corporate QC, AstraZeneca


patent

Develop A Patent Strategy To Achieve Business Purposes

2019-02-23

Cheng Zhang

Co-founder, TiPLab


analytical

Establishing a Comprehensive and Robust Quality Management Systems to meet cGMP Regulation Requirements

2019-04-27

Susan Qu

Director, Thermo Fisher Scientific


discovery

Therapeutic Antibody Discovery and Development

2019-05-26

Haichun Huang

CSO, NovaRock Biotherapeutics


target biology

Differential Biomarkers and Treatment Strategies for PD-1 pathway blockade-based Immunotherapy in Asia

2019-06-22

Sheng Yao

SVP, Shanghai Junshi Biosciences


patent

Dana-Farber v. Ono: A look at U.S. joint inventorship law

2019-07-27

Limin Zheng

Partner, Miclean Gleason LLP


clinical trials

Statistics in clinical trials

2019-08-17

Xiang (Tony) Guo

Excutive Director/Head of Biometrics in APAC, BeiGene


analytical

The Roles of Liquid Chromatography and Mass Spectrometry in the Development of Antibody‐Based Therapeutics

2019-09-28

Weibin Chen

Director, Waters Corporation


discovery

Propelling protein drug discovery by paring of human orphan receptors / ligands

2020-01-18

Wei Yang

Director, Protein Innovation


patent

IP Considerations in Cross-Border Transactions – In the Wake of the Phase I US-China Trade Deal

2020-03-01

Janet Xiao

Partner, Morrison & Forster LLP


manufacturing

How Biomanufacturing is Evolving to Address Current and Future Challenges

2020-03-28

Chris Hwang

CTO, Transcenta


discovery

E2E Biologics Platform – From Discovery to Bioprocess

2020-04-25

Yuan Lin

Biologics Business Partner and Solution Lead , Pfizer


discovery

MabPair Platform- An Innovative Approach to Develop Antibody Combination Therapy

2020-05-23

Wei Yan

Founder, Sound Biologics


covid-19

Cross-neutralizing Human Monoclonal Antibody Offers Opportunity for Treatment and Prevention of COVID-19

2020-06-06

Jingsong Wang

Founder, Harbour BioMed

Icon
Open Sidebar Open Sidebar
Quick Navigate (newest first)
COVID-19
Target Biology
Discovery
Upstream
Downstream
Analtyical, QA/QC
Clinical Trials
Manufacturing
Regulatory
Patent
Business